Jane Street’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Jane Street’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,076	Closed	-$36.3K	–	9692
2023 Q2	$36.3K	Buy	+20,076	New	+$36.7K	﹤0.01%	8274
2023 Q1	–	Sell	-21,473	Closed	-$36.3K	–	10315
2022 Q4	$36.3K	Buy	+21,473	New	+$27.2K	﹤0.01%	8458
2022 Q2	–	Sell	-16,771	Closed	-$121K	–	11306
2022 Q1	$121K	Buy	+16,771	New	+$165K	﹤0.01%	9362

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street's PRDS Position: Q3 2023 in Review

Jane Street sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 20,076 shares — an estimated $36.3K sold.

Jane Street first reported a position in PRDS in Q1 2022 and held it in 3 quarters. The position peaked at $121K in Q1 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Jane Street reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 20,076 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $36.3K.
Jane Street first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Jane Street's Pardes Biosciences, Inc. Common Stock position peaked at $121K in Q1 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.